Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer’s Disease-Reference-Cited by-同舟云学术

Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer’s Disease

Published:2020-03-10 Issue:1 Volume:74 Page:277-286
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Jääskeläinen Olli¹,Hall Anette¹,Tiainen Mika²,van Gils Mark³,Lötjönen Jyrki⁴,Kangas Antti J.⁵,Helisalmi Seppo¹,Pikkarainen Maria¹,Hallikainen Merja¹⁶,Koivisto Anne¹⁶,Hartikainen Päivi⁶,Hiltunen Mikko⁷,Ala-Korpela Mika²⁵⁸⁹¹⁰,Soininen Pasi²,Soininen Hilkka¹⁶,Herukka Sanna-Kaisa¹⁶

Affiliation:

1. Institute of Clinical Medicine – Neurology, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland

2. NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland

3. VTT Technical Research Centre of Finland Ltd, Tampere, Finland

4. Combinostics Ltd, Tampere, Finland

5. Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland

6. Neurocenter, Kuopio University Hospital, Kuopio, Finland

7. Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland

8. Medical Research Council Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom

9. Population Health Science, Bristol Medical School, University of Bristol, Bristol, United Kingdom

10. Systems Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference34 articles.

1. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease;Bateman;N Engl J Med,2012

2. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia;Simonsen;Alzheimers Dement,2017

3. Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria;Dubois;Lancet Neurol,2007

4. Advancing research diagnostic criteria for Alzheimer’s disease: The IWG-2 criteria;Dubois;Lancet Neurol,2014

5. Mild cognitive impairment as a diagnostic entity;Petersen;J Intern Med,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of Using Magnetic Resonance Spectroscopy Test Biomarkers to Diagnose Alzheimer's Disease: Systematic Evaluation and Meta-Analysis;Actas Españolas de Psiquiatría;2024-04-05

2. Integrative Multimodal Metabolomics to Early Predict Cognitive Decline Among Amyloid Positive Community-Dwelling Older Adults;The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences;2024-03-07

3. Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer’s disease;Alzheimer's Research & Therapy;2023-10-14

4. Non-invasive biomarkers for mild cognitive impairment and Alzheimer's disease;Neurobiology of Disease;2023-10

5. Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer’s disease patients;Frontiers in Aging Neuroscience;2023-08-24